Ching-Ping Chen

762 total citations
9 papers, 511 citations indexed

About

Ching-Ping Chen is a scholar working on Organic Chemistry, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Ching-Ping Chen has authored 9 papers receiving a total of 511 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Organic Chemistry, 4 papers in Molecular Biology and 2 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Ching-Ping Chen's work include Synthesis and biological activity (4 papers), Click Chemistry and Applications (3 papers) and Cancer therapeutics and mechanisms (2 papers). Ching-Ping Chen is often cited by papers focused on Synthesis and biological activity (4 papers), Click Chemistry and Applications (3 papers) and Cancer therapeutics and mechanisms (2 papers). Ching-Ping Chen collaborates with scholars based in Taiwan. Ching-Ping Chen's co-authors include Chiung-Tong Chen, Hsing‐Pang Hsieh, Jing‐Ping Liou, Jang‐Yang Chang, Ching‐Chuan Kuo, Shiow‐Ju Lee, Wen-Yu Pan, Li‐Tzong Chen, Chi-Hung Lin and Hua-Chien Chen and has published in prestigious journals such as Cancer Research, Journal of Medicinal Chemistry and European Journal of Medicinal Chemistry.

In The Last Decade

Ching-Ping Chen

9 papers receiving 500 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ching-Ping Chen Taiwan	8	359	200	66	42	37	9	511
Rajesh Kakadiya Taiwan	16	506 1.4×	335 1.7×	86 1.3×	37 0.9×	35 0.9×	35	695
Jimi Marin Alex India	13	319 0.9×	318 1.6×	70 1.1×	18 0.4×	27 0.7×	16	626
Mohamed Elsayed United States	11	216 0.6×	215 1.1×	57 0.9×	29 0.7×	21 0.6×	19	421
Zizhao Guo China	9	248 0.7×	229 1.1×	132 2.0×	36 0.9×	24 0.6×	11	403
Beatrice Bechi United Kingdom	9	421 1.2×	248 1.2×	72 1.1×	12 0.3×	43 1.2×	11	637
Yuya Oguro Japan	11	205 0.6×	263 1.3×	99 1.5×	39 0.9×	28 0.8×	15	450
Paul Erdman United States	10	186 0.5×	185 0.9×	63 1.0×	15 0.4×	21 0.6×	18	384
Yuru Liang China	12	269 0.7×	204 1.0×	40 0.6×	22 0.5×	36 1.0×	28	396
Jean‐Michel Robert France	11	261 0.7×	169 0.8×	43 0.7×	22 0.5×	28 0.8×	19	412
Defeng Tian United States	9	206 0.6×	174 0.9×	44 0.7×	31 0.7×	95 2.6×	14	381

Countries citing papers authored by Ching-Ping Chen

Since Specialization

Citations

This map shows the geographic impact of Ching-Ping Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ching-Ping Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ching-Ping Chen more than expected).

Fields of papers citing papers by Ching-Ping Chen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ching-Ping Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ching-Ping Chen. The network helps show where Ching-Ping Chen may publish in the future.

Co-authorship network of co-authors of Ching-Ping Chen

This figure shows the co-authorship network connecting the top 25 collaborators of Ching-Ping Chen. A scholar is included among the top collaborators of Ching-Ping Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ching-Ping Chen. Ching-Ping Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

Lin, Shu‐Yu, Yi-Yu Ke, Wen‐Hsing Lin, et al.. (2019). Discovery of a Furanopyrimidine-Based Epidermal Growth Factor Receptor Inhibitor (DBPR112) as a Clinical Candidate for the Treatment of Non-Small Cell Lung Cancer. Journal of Medicinal Chemistry. 62(22). 10108–10123. 30 indexed citations

Chen, Chiung-Tong, John T.-A. Hsu, Wen‐Hsing Lin, et al.. (2015). Identification of a potent 5-phenyl-thiazol-2-ylamine-based inhibitor of FLT3 with activity against drug resistance-conferring point mutations. European Journal of Medicinal Chemistry. 100. 151–161. 8 indexed citations

Yeh, Teng-Kuang, Jen-Shin Song, Yung‐Ning Yang, et al.. (2013). BPR0C305, an orally active microtubule-disrupting anticancer agent. Anti-Cancer Drugs. 24(10). 1047–1057. 7 indexed citations

Chen, Ching-Ping, Kai‐Chia Yeh, Jen-Shin Song, et al.. (2010). Antiangiogenic activities and cisplatin-combined antitumor activities of BPR0L075.. PubMed. 30(7). 2813–22. 12 indexed citations

Song, Jen-Shin, Ching-Ping Chen, Jiunn‐Jye Chuu, et al.. (2010). Synthesis and Biological Activities of 2-Amino-1-arylidenamino Imidazoles as Orally Active Anticancer Agents. Journal of Medicinal Chemistry. 53(6). 2409–2417. 37 indexed citations

Yeh, Kai‐Chia, Ching-Ping Chen, Chien-Chang Shen, et al.. (2009). Intravenous paclitaxel against metastasis of human gastric tumors of diffuse type. Cancer Chemotherapy and Pharmacology. 66(4). 773–783. 7 indexed citations

Wu, Yu-Shan, Mohane Selvaraj Coumar, Jang‐Yang Chang, et al.. (2009). Synthesis and Evaluation of 3-Aroylindoles as Anticancer Agents: Metabolite Approach. Journal of Medicinal Chemistry. 52(15). 4941–4945. 82 indexed citations

Kuo, Ching‐Chuan, Hsing‐Pang Hsieh, Wen-Yu Pan, et al.. (2004). BPR0L075, a Novel Synthetic Indole Compound with Antimitotic Activity in Human Cancer Cells, Exerts Effective Antitumoral Activityin Vivo. Cancer Research. 64(13). 4621–4628. 182 indexed citations

Chen, Ching-Ping, Chi-Hung Lin, Yingying Chang, et al.. (2003). Synthesis and Biological Evaluation of N-Heterocyclic Indolyl Glyoxylamides as Orally Active Anticancer Agents. Journal of Medicinal Chemistry. 46(9). 1706–1715. 146 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact